We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly’s Antibody Med Shows Potential in Preventing COVID-19 in the Elderly
Eli Lilly’s Antibody Med Shows Potential in Preventing COVID-19 in the Elderly
Eli Lilly reported yesterday that its monoclonal antibody bamlanivimab (LY-CoV555) significantly lessened the risk of contracting COVID-19 among nursing home residents and staff, according to findings from a phase 3 trial.